Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy
Melody SmithCellular Therapeutics Center, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USAAnqi DaiAdult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USAGuido GhilardiDivision of Hematology-Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USAKimberly V. AmelsbergCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USASean M. DevlinDepartment of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY, USARaymone PajarilloCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USAJohn SlingerlandAdult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USASilvia BeghiDepartment of Radiation Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USAPamela S. HerreraWeill Cornell Medical College, New York, NY, USAPaul A. GiardinaAdult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USAAnnelie ClurmanAdult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USAEmmanuel Agyemang DwomohAdult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USAGabriel K. ArmijoAdult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USAAntonio L. C. GomesAdult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USAEric R. LittmannThe Duchossois Family Institute, University of Chicago, Chicago, IL, USAJonas SchlüterInstitute for Computational Medicine, New York University Langone Health, New York, NY, USAEmily FontanaMolecular Microbiology Core Facility, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USAYing TaurInfectious Disease Service, Department of Medicine, and Immunology Program, Sloan Kettering Institute, New York, NY, USAJae H. ParkDepartment of Medicine, Weill Cornell Medical College, New York, NY, USAMaria Lia PalombaCellular Therapeutics Center, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USAElizabeth HaltonCellular Therapeutics Center, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USAJosel D. RuizAdult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USATania JainSidney Kimmel Comprehensive Cancer CenterMartina PennisiDepartment of Oncology and Hemato-Oncology, University of Milan, Milan, ItalyAishat Olaide AfuyeAdult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USAMiguel‐Angel PeralesAdult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USACraig W. FreyerDepartment of Pharmacy, Hospital of the University of Pennsylvania, Philadelphia, PA, USAAlfred L. GarfallCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USAShannon GierCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USASunita D. NastaCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USADaniel J. LandsburgCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USAJames N. GersonLymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USAJakub SvobodaCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USAJustin R. CrossThe Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, NY, USAElise A. ChongDivision of Hematology-Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USASergio GiraltAdult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USASaar GillCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USAIsabelle RivièreCellular Therapeutics Center, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USADavid L. PorterDivision of Hematology-Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USAStephen J. SchusterCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USAMichel SadelainCenter for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USANoelle V. FreyCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USARenier J. BrentjensCenter for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USACarl H. JuneCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USAEric G. PamerThe Duchossois Family Institute, University of Chicago, Chicago, IL, USAJonathan U. PeledAdult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USAAndrea FacciabeneOvarian Cancer Research Center, University of Pennsylvania, Philadelphia, PA, USA. [email protected]Marcel R.M. van den BrinkDepartment of Immunology, Sloan Kettering Institute, New York, NY, USA. [email protected]Marco RuellaLymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA. [email protected]
2022en
ABI
Annotatsiya
Annotatsiya mavjud emas.
Identifikatorlar
Iqtiboslar va manbalar
2 ta iqtibos0 ta foydalanilgan manba